Search clinical trials for: Glucovance (metformin HCl/glyburide)

Total 121 results

Bristol-Myers Squibb

Completed

A Research Study to Determine the Safety and Efficacy of Glucovance Compared to Metformin and Glyburide in Children and Adolescents With Type 2 Diabetes.

Diabetes Mellitus, Non-Insulin-Dependent

United States
Bristol-Myers Squibb

Completed

A Research Study to Assess the Mechanism By Which Glucovance, Metformin, and Glyburide Work To Control Glucose Levels In Patients With Type 2 Diabetes

Diabetes Mellitus, Non-Insulin-Dependent

United States
Regional Obstetrical Consultants

Unknown

Comparison of Glucovance to Insulin for Diabetes During Pregnancy

Pregnancy | Type 2 Diabetes | Gestational Diabetes

United States
Texas Tech University Health Sciences Center, El...

Terminated

Glyburide vs Glucovance in the Treatment of GDM (GGIG)

Gestational Diabetes

United States
Teva Pharmaceuticals USA

Completed

Glyburide/Metformin 5 mg/500 mg Film-Coated Tablets, Fasting

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Glyburide/Metformin 5 mg/500 mg Film-Coated Tablets, Fed

Healthy

Canada
Hospital de Clinicas de Porto Alegre

Unknown

Oral Antidiabetic Agents in Pregnancy

Gestational Diabetes

Brazil
Actavis Inc.

Completed

A Relative Bioavailability Study of Glyburide/Metformin HCl 5 mg/500 mg Tablets Under Fasting Conditions

Healthy

United States
Actavis Inc.

Completed

A Relative Bioavailability Study of Glyburide/Metformin HCl 5 mg/500 mg Tablets Under Non-fasting Conditions

Healthy

United States
Actavis Inc.

Completed

A Relative Bioavailability Study of Glyburide/Metformin HCl 5 mg/500 mg Tablets Under Fasting Conditions

Healthy

United States
University of Texas Southwestern Medical Center

Completed

Preservation of Beta-cell Function in Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

United States
GlaxoSmithKline

Completed

Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide

Diabetes Mellitus, Type 2

United States, Germany, Canada, Belgium, Denmark, Spain, Ireland, Netherlands, United Kingdom, Hungary, Italy, France, Austria, Czechia, Norway, Finland, Sweden
Eunice Kennedy Shriver National Institute of Child...
University of Pittsburgh; University of Washington; University of Texas; RTI International and other collaborators

Unknown

Glyburide and Metformin for Gestational Diabetes Mellitus (GDM) (GDM)

Gestational Diabetes Mellitus

United States
Fundació Institut de Recerca de l'Hospital de la...

Completed

Glyburide and Metformin for the Treatment of Gestational Diabetes Mellitus. Systematic Review

Gestational Diabetes Mellitus

Spain
Brigham and Women's Hospital
Patient-Centered Outcomes Research Institute; McGill University; VA Boston Healthcare...

Active, not recruiting

Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study (CER-4-T2D)

Type2 Diabetes | Renal Disease | Cardiovascular Events

United States
Université de Sherbrooke
Fonds de la Recherche en Santé du Québec

Completed

Gestational Diabetes: Insulin or Oral Hypoglycemic Agents? (DG5)

Gestational Diabetes Mellitus

Canada
University of Maryland, Baltimore

Not yet recruiting

Investigation of the Efficacy of Metformin Therapy on Pulmonary Sarcoidosis (MetforminTOP)

Sarcoidosis, Pulmonary
HaEmek Medical Center, Israel

Completed

A Comparison Between Two Oral Hypoglycemics - Metformin and Glybenclamide for the Treatment of Gestational Diabetes Mellitus

Gestational Diabetes Mellitus

Israel
University of New Mexico

Completed

Metformin Compared to Glyburide in Gestational Diabetes

Gestational Diabetes

United States
LG Life Sciences

Completed

BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 1000mg in Comparison to Each Component Administered Alone

Healthy

Korea, Republic of
Daiichi Sankyo, Inc.

Terminated

Randomized, Double-blind, Active-controlled, Study of Rivoglitazone in Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

United States
LG Life Sciences

Unknown

BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 2000mg in Comparison to Each Component Administered Alone

Healthy

Korea, Republic of
LG Life Sciences

Completed

BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 500mg in Comparison to Each Component Administered Alone

Healthy

Korea, Republic of
LG Life Sciences

Completed

BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 1000mg in Comparison to Each Component Administered Alone.

Healthy

Korea, Republic of
The University of Texas Health Science Center,...

Withdrawn

Failure Rate of GLyburide And Metformin Among Gestational Diabetics (GLAM)

Gestational Diabetes Mellitus, Class A2
The University of Texas Health Science Center at...
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); American... and other collaborators

Completed

Durability of Combination Therapy With Exenatide/Pioglitazone/Metformin vs. Conventional Therapy in New Onset T2DM

Diabetes

United States
LG Chem

Completed

BE Study of the Combinations of Gemigliptin/Metformin HCl Extended Release 50/1000mg(25/500mg x 2 Tablets) in Comparison to Each Component Administered Alone

Healthy Male Volunteers

Korea, Republic of
Boston Children's Hospital

Completed

Pilot Study of Metformin for Patients With Fanconi Anemia

Fanconi Anemia

United States
University of California, San Francisco

Completed

Impact of Genetics on Metformin Pharmacokinetics

Other Conditions That May Be A Focus of Clinical Attention

United States
Children's Hospital Los Angeles

Terminated

Metformin and Transient Hyperglycemia

Hyperglycemia | Diabetes Mellitus | Insulin Resistance | Acute Lymphoblastic Leukemia

United States
Maisa N. Feghali, MD

Completed

Metabolic Analysis for Treatment Choice in Gestational Diabetes Mellitus (MATCh-GDM)

Gestational Diabetes | Diabetes, Gestational | Pregnancy in Diabetes

United States
University of California, Davis
National Cancer Institute (NCI); Astellas Pharma Inc; Medivation, Inc.

Active, not recruiting

Enzalutamide and Metformin Hydrochloride in Treating Patients With Hormone-Resistant Prostate Cancer

Prostate Cancer

United States
Torrent Pharmaceuticals Limited

Completed

Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Metformin HCl (1000 mg), Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Glucophage®, Bristol-Myers Squibb Company) in Fasted, Healthy, Adult Subjects

Healthy

United States
Torrent Pharmaceuticals Limited

Completed

Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Metformin HCl (1000 mg), Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Glucophage®, Bristol-Myers Squibb Company) in Fed, Healthy, Adult Subjects

Healthy

United States
Takeda

Completed

Efficacy and Safety of Pioglitazone in Treating Subjects With Vascular Complications Associated With Type 2 Diabetes Mellitus. (SPLENDOR)

Diabetes Mellitus

Italy
Cubist Pharmaceuticals LLC
GlaxoSmithKline

Completed

Clinical Outcomes After Bowel Resection in Patients Receiving Alvimopan Versus Patients Not Receiving Alvimopan in the Premier Perspective Database

Ileus

United States
Laboratorios Silanes S.A. de C.V.
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Unknown

Efficacy Study of Metformin Glycinate on Postprandial Lipemia

Type 2 Diabetes

Mexico
Chong Kun Dang Pharmaceutical

Completed

A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/750 mg in Healthy Male Volunteers

Diabetes Mellitus, Type II

Korea, Republic of
University of Virginia
Merck Sharp & Dohme LLC

Completed

Trial of Alvimopan in Major Spine Surgery

Constipation

United States
Jack Yanovski, M.D.
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Metformin to Treat Obesity in Children With Insulin Resistance

Obesity | Hyperinsulinemia

United States
University of Zambia
University Teaching Hospital, Lusaka, Zambia

Not yet recruiting

Glycaemic & Cardiovascular Treatment Outcomes of Voglibose Vs Glibenclamide Added to Metformin in T2DM Patients (VMGMProtocol)

Diabetes Mellitus Type 2 Without Complication
Mina Chung, MD
The Cleveland Clinic; American Heart Association

Active, not recruiting

Targeting Risk Interventions and Metformin for Atrial Fibrillation (TRIM-AF) (TRIM-AF)

Atrial Fibrillation

United States
UConn Health

Completed

Vaccination Efficacy With Metformin in Older Adults (VEME)

Aging | Vaccine Response Impaired | Age-Related Immunodeficiency

United States
Cubist Pharmaceuticals LLC

Completed

A Study of Alvimopan for the Management of Postoperative Ileus in Participants Undergoing Radical Cystectomy

Postoperative Ileus

United States
National Cancer Institute (NCI)

Active, not recruiting

Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion

Hyperplasia | Oral Cavity Carcinoma | Oral Leukoplakia | Erythroplakia

United States, Canada
Sandoz

Completed

A Relative Bioavailability Study of Metformin HCL Tablets, 1000 mg Under Fasting Conditions

Type 2 Diabetes
Ain Shams University

Unknown

Cancer Chemoprevention by Metformin Hydrochloride Compared to Placebo in Oral Potentially Malignant Lesions

Oral Cancer

Egypt
American University of Beirut Medical Center

Recruiting

A Multidisciplinary Weight Loss Program at AUB-MC

Obesity | Weight Loss

Lebanon
Sanofi

Completed

Insulin Glargine in Type 2 Diabetic Patients (TARGET)

Diabetes Mellitus, Type 2

China
Daiichi Sankyo, Inc.

Completed

Effects of Metformin Hydrochloride (HCl) in Combination With Colesevelam HCl, Compared to Metformin HCl Alone, in Patients With Type 2 Diabetes Mellitus and the Effects of Colesevelam HCl on Lipids and Glucose on Pre-diabetic Patients.

Type 2 Diabetes Mellitus | Hypercholesterolemia | Pre-diabetes

United States, Colombia, India, Mexico

3

Subscribe